trilaciclib
Generic: trilaciclib·Brand: COSELA
trilaciclib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| G1 Therapeutics, Inc. (GTHX) | Phase 3 |
Clinical Trials (1)
Phase 2 Study of Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib in Patients With Untreated Extensive-Stage Small Cell Lung Cancer (SCLC)
Frequently asked questions
Who is developing trilaciclib?
trilaciclib is being developed by G1 Therapeutics, Inc..
How many clinical trials involve trilaciclib?
BioSniper tracks 1 clinical trial involving trilaciclib.
Get deeper analysis on trilaciclib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis